In addition, intratumoural injection of ARL67156 increased the radiosensitivity of ATG5-deficient (ATG5KD) tumour cells in an immunocompetent context, indicating that it restored the immune response to irradiated ATG5KD CT26 tumour cells (Figure 4d). This evidence concerns the gene ATG5 and neoplasm.